142 related articles for article (PubMed ID: 25368257)
21. Reduced
Boss SD; Müller C; Siwowska K; Büchel JI; Schmid RM; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2018 Apr; 29(4):1119-1130. PubMed ID: 29412638
[TBL] [Abstract][Full Text] [Related]
22. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
23. Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates.
Müller C; Vlahov IR; Santhapuram HK; Leamon CP; Schibli R
Nucl Med Biol; 2011 Jul; 38(5):715-23. PubMed ID: 21718947
[TBL] [Abstract][Full Text] [Related]
24. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors.
Ross TL; Honer M; Müller C; Groehn V; Schibli R; Ametamey SM
J Nucl Med; 2010 Nov; 51(11):1756-62. PubMed ID: 20956469
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of a (68)Ga labeled folic acid derivative for targeting folate receptors.
Jain A; Mathur A; Pandey U; Bhatt J; Mukherjee A; Ram R; Sarma HD; Dash A
Appl Radiat Isot; 2016 Oct; 116():77-84. PubMed ID: 27501138
[TBL] [Abstract][Full Text] [Related]
27. Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent.
AlHokbany N; AlJammaz I; AlOtaibi B; AlMalki Y; AlJammaz B; Okarvi SM
EJNMMI Radiopharm Chem; 2022 Jul; 7(1):19. PubMed ID: 35870027
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
29. Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates.
Müller C; Guzik P; Siwowska K; Cohrs S; Schmid RM; Schibli R
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914162
[TBL] [Abstract][Full Text] [Related]
30. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
31. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Müller C; Struthers H; Winiger C; Zhernosekov K; Schibli R
J Nucl Med; 2013 Jan; 54(1):124-31. PubMed ID: 23236020
[TBL] [Abstract][Full Text] [Related]
32. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
[TBL] [Abstract][Full Text] [Related]
33. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
[TBL] [Abstract][Full Text] [Related]
34. Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast.
Reber J; Struthers H; Betzel T; Hohn A; Schibli R; Müller C
Mol Pharm; 2012 May; 9(5):1213-21. PubMed ID: 22509996
[TBL] [Abstract][Full Text] [Related]
35. Radiosynthesis and biological evaluation of 68Ga-labeled colchicine conjugates.
Satpati D; Korde A; Sarma HD; Banerjee S
Cancer Biother Radiopharm; 2014 Aug; 29(6):251-6. PubMed ID: 24983126
[TBL] [Abstract][Full Text] [Related]
36. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18.
Boss SD; Betzel T; Müller C; Fischer CR; Haller S; Reber J; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2016 Jan; 27(1):74-86. PubMed ID: 26634288
[TBL] [Abstract][Full Text] [Related]
37. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of
Choi PS; Lee JY; Park JH; Kim SW
J Labelled Comp Radiopharm; 2018 Jan; 61(1):4-10. PubMed ID: 28901564
[TBL] [Abstract][Full Text] [Related]
39. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics.
Deberle LM; Benešová M; Becker AE; Ratz M; Guzik P; Schibli R; Müller C
Bioconjug Chem; 2021 Aug; 32(8):1617-1628. PubMed ID: 34251183
[TBL] [Abstract][Full Text] [Related]
40. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
Rossin R; Pan D; Qi K; Turner JL; Sun X; Wooley KL; Welch MJ
J Nucl Med; 2005 Jul; 46(7):1210-8. PubMed ID: 16000291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
